symptomatic infection – Page 8 – Communicable Diseases Research

Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection

SARS-CoV-2 감염에 대한 자가항체 반응의 역설적인 성별 특정 패턴

Research

Published on 2021-12-302022-09-10
Journal: Journal of Translational Medicine [Category] SARS, 진단, 치료법,

[키워드] AABs absence Activation acute response age analyses antibody Antigen antigens assigned asymptomatic infection autoantibody autoantigen Autoantigen selectivity Autoimmune Autoimmune disease Autoimmune diseases autoreactivity blood draw breadth classic clinical disease Clustering Cohort collected COVID-19 COVID-19 illness demographic data effective intervention effective interventions Evidence evidence of exhibit extreme greater healthy control homology Immune-mediated inflammatory activity lead men men and women modulating molecular multivariable analyses nucleocapsid protein number of symptom participant presence or absence Prevalence reactivity reported symptom reported symptoms Result SARS-CoV-2 SARS-COV-2 infection serological severe COVID-19 illness Sex difference sex differences socio-demographic supplementary material susceptibility Symptom symptomatic infection Symptoms trajectory triggered within 6 months women
[DOI] 10.1186/s12967-021-03184-8 PMC 바로가기 [Article Type] Research

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

초기 SARS-COV-2 환자에서 Molnupiravir의 최적 용량 및 안전성 : A 상 I, 오픈 라벨, 용량-에스calating, 무작위 대조 연구

Randomized Controlled Trial

Published on 2021-12-272022-08-13
Journal: Journal of Antimicrobial Chemotherapy [Category] MERS, SARS, 임상,

Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)

Research Theme 1: COVID-19 Pandemic

Published on 2021-12-252022-10-31
Journal: Journal of Global Health [Category] COVID-19, SARS,

[키워드] acute respiratory syndrome adjusted Admissions adverse event age Analysis approval association case control study children Cohort Comorbidities confounders coronavirus COVID-19 COVID-19 cases COVID-19 infection COVID-19 vaccination COVID-19 vaccine Cox model death defined determine dissemination dose doses East Effectiveness enhanced Ethics ethics committee first dose group groups hospitalisation hospitalisations ICU ICU admission intensive care International multivariable logistic regression National negative outcome pandemic peer-reviewed Poisson regression models Primary outcome prospective cohort study public health reported risk SARS-CoV-2 second dose Severity of disease Sex South Study design Surveillance symptomatic infection symptomatic SARS-CoV-2 infection Test Transmission unique uptake vaccination Vaccination Status Vaccine Vaccines variable was obtained
[DOI] 10.7189/jogh.11.05026 PMC 바로가기 [Article Type] Research Theme 1: COVID-19 Pandemic

Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant

Covid-19의 증상의 발병 모델링 : SARS-Cov-2 변이체의 영향

Research Article

Published on 2021-12-162022-09-10
Journal: PLoS Computational Biology [Category] SARS, 변종,

[키워드] Affect age Analysis changed Characteristics China Comorbidities Comorbidity condition contagious cough coughing COVID-19 case COVID-19 symptom COVID-19 symptoms D614G D614G variant Data collection Diagnosis diarrhea disease Disease progression disease spread Effect Europe explained Fever First wave Google greater transmissibility identifying in viral infected individual infected individuals Infectious disease Infectious diseases Influenza initial Intervention Japan mathematical mathematical model modeling Mutation nausea nausea/vomiting not affect occur Occurrence onset of symptom other infectious diseases outbreak Patient patient age patient data predict predicted raise reducing reference strain researcher SARS-CoV-2 SARS-CoV-2 variant Spread Support supported Supporting Symptom symptom onset symptomatic symptomatic infection symptomatic infections the SARS-CoV-2 trend USA variants of SARS-CoV-2 Viral viral disease viral variant virus vomiting weather Wuhan
[DOI] 10.1371/journal.pcbi.1009629 PMC 바로가기 [Article Type] Research Article

Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021

Systematic Review

Published on 2021-12-162022-10-28
Journal: Vaccines [Category] COVID-19,

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

카타르에서 SARS-CoV-2 감염에 대한 BNT162b2 백신 보호 약화

Article

Published on 2021-12-092022-09-11
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 변종,

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

6개월 동안 BNT162b2 Covid-19 백신에 대한 면역 체액 반응 약화

Article

Published on 2021-12-092022-09-12
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 진단,

Effectiveness of BNT162b2 and ChAdOx1 Vaccines against Symptomatic COVID-19 among Healthcare Workers in Kuwait: A Retrospective Cohort Study

Article

Published on 2021-12-072022-10-31
Journal: International journal for equity in health [Category] COVID-19,

SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity

Research Articles

Published on 2021-12-062022-10-31
Journal: Microbial Genomics [Category] COVID-19, SARS,

COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study

Article

Published on 2021-12-062022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] addressed Administered booster booster dose booster immunization carried circulating variant Community community transmission COVID-19 COVID-19 infection COVID-19 vaccine COVID-19 vaccines cross-sectional Czechia Decision making demographic characteristics determinant driver Effectiveness Europe evaluate female females groups HCW Health Health personnel healthcare worker Hesitancy Immunity inoculated male MOST National occurred Older participant Participants Patient professionals public health public health messaging questionnaire receive SARS-CoV-2 SARS-CoV-2 variant symptomatic infection Vaccine worker
[DOI] 10.3390/vaccines9121437 PMC 바로가기 [Article Type] Article